May. 26 at 12:42 PM
$ODD $EL $ELF
Initiated small position only: ODD: Trading as if Valued at Zero Amid Severe Undervaluation. 
Disclaimer: This is only for High risk tolerant traders but worth looking. In my opinion, the main Issue, Customer Acquisition cost is fixable bit it is all about timeline issue. If this will take longer to fix then stock maybe depress for a while but if management says Fix is current going we then we may see a big jump on earning date.
Oddity Tech is a consumer tech platform that builds and scales digital-first beauty and wellness brands using AI, data science, computer vision, and personalization. Its core offering revolves around proprietary quizzes, hyperspectral imaging via smartphone cameras, and “Try Before You Buy” models that deliver highly tailored products. The stock has been hammered — trading near
$12.32 (as of late May 2026), sharply down from 2025 highs near
$79 — due to a temporary ad platform disruption spiking customer acquisition costs (CAC). This triggered a ~30% YoY revenue decline warning for Q1 2026 and guidance suspension. 
The market is pricing ODD as if the operating business is worth close to zero (or negative), despite a cash fortress, high-quality recurring revenue, strong brands, and clear growth drivers.
This creates an exceptional asymmetric risk-reward setup.
1. Fortress Balance Sheet – Cash Dominates the Valuation
• Massive cash position: Approximately
$776 million in cash, equivalents, and investments, rivaling or exceeding the current ~
$700 million market cap. 
• Extremely strong net cash with low debt. Enterprise value implies the market assigns near-zero value to the profitable operating business and its brands. This provides a huge downside buffer and fuel for buybacks/investments.
2. Aggressive Capital Return and Alignment
• Share buybacks: Board authorized programs (including a
$200M plan), with management highlighting attractiveness at current levels. Highly accretive when the business trades like it’s worthless. 
3. Strong Product Portfolio and High-Quality Business Model
Main beauty/wellness products:
• IL Makiage: Flagship makeup brand focused on color cosmetics. Uses AI-powered personalization (quiz + imaging) for foundations, lipsticks, eyeshadows, and full makeup lines. Known for broad shade ranges, high efficacy, and shifting customers from offline to online. Contributed the majority of revenue historically (over
$500M in 2024). 
• SpoiledChild: Anti-aging and wellness brand launched in 2022. Offers intelligent skin and hair products (serums, creams, treatments) plus supplements. Powered by SpoiledBrain AI for personalized recommendations. Focuses on refusing to “take aging seriously” with high-efficacy, refillable packaging. Strong in skincare, haircare, and wellness. 
Upcoming/Recent expansions:
• METHODIQ (launched November 2025): Third brand — a telehealth/medical-grade skincare platform targeting acne, eczema, hyperpigmentation, rosacea, and related issues. Combines AI diagnostics, teledermatology consultations, and over 28 products (prescription, OTC, and proprietary). Includes personalized regimens (100+ plans) with items like Clarixa (hormonal/gut health), Zeralaq (acne/scar), Fibrexa (barrier repair), and functional makeup like SkinShield Foundation. Leverages Oddity Labs (biotech arm) for AI-discovered molecules. 
• Oddity Labs pipeline: Expect 8 products in market in 2026 using proprietary molecules (focused on acne, eczema, hyperpigmentation). Early traction in color cosmetics and medical categories. Potential fourth brand in development for further expansion. 
Business strengths:
• Exceptional margins (~70-73% gross).
• High repeat customers: ~70%+ of revenue from repeats, with >100% net revenue retention in cohorts.
• Proven growth: 24-27%+ YoY pre-disruption, plus international and new verticals.
4. Fixable CAC Issue – Temporary Overhang with Leverage
The spike stems from ad algorithm changes routing to low-quality auctions. Management has identified fixes, expects Q2 improvement and H2 2026 normalization. Recovery should re-accelerate growth via high LTV repeats, new METHODIQ momentum, and pipeline innovation. 
5. Extreme Undervaluation – Asymmetric Risk-Reward
• Low multiples (~6-7x P/E on TTM).
• Analyst targets suggest significant upside; intrinsic models point to 30-300%+ potential in recovery.
• Trades like zero for the business: Cash covers the valuation, with brands, tech moat, and pipeline as upside optionality. Downside supported; upside highly asymmetric (multi-bagger potential).
Insider note: Some routine selling, but buybacks and commentary show confidence. 
Risks: CAC normalization timeline, ad dependency, competition, macro spending, and new brand execution. The temporary issue, cash strength, loyal customers, and product innovation tilt the setup positively.
In summary, ODD is a high-margin tech-enabled beauty compounder with standout products (IL Makiage, SpoiledChild, METHODIQ) and a robust pipeline — trading at deep value as if the business is worthless. CAC resolution and rerating could drive strong returns. Not financial advice; do your own research.
